BNP/CALL/SARTORIUS STEDIM BIO/280/0.01/20.09.24 Share Price

Warrant

DE000PC21T45

Market Closed - Boerse Frankfurt Warrants 20:20:40 28/05/2024 BST
0.01 EUR -9.09% Intraday chart for BNP/CALL/SARTORIUS STEDIM BIO/280/0.01/20.09.24
Current month-73.68%
1 month-80.00%
Date Price Change
28/05/24 0.01 -9.09%
27/05/24 0.011 -21.43%
24/05/24 0.014 0.00%
23/05/24 0.014 -22.22%
22/05/24 0.018 0.00%

Real-time Boerse Frankfurt Warrants

Last update May 28, 2024 at 08:20 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC21T4
ISINDE000PC21T45
Date issued 05/01/2024
Strike 280
Maturity 20/09/2024 (115 Days)
Parity 100 : 1
Emission price 0.24
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.37
Lowest since issue 0.01
Delta0.09x
Omega 8.843
Premium51.18x
Gearing95.64x
Moneyness 0.6661
Difference Strike 93.5
Difference Strike %+33.39%
Spread 0.019
Spread %65.52%
Theoretical value 0.0195
Implied Volatility 48.08 %
Total Loss Probability 94.47 %
Intrinsic value 0.000000
Present value 0.0195
Break even 281.95 €
Theta-0x
Vega0x
Rho0x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
186.5 EUR
Average target price
248.8 EUR
Spread / Average Target
+33.42%
Consensus